This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sim, J. S. Articles by Struthers, A. D Search for Related Content PubMed PubMed Citation Articles by Sim, J. S. Articles by Struthers, A. D Social Bookmarking                   What's this?

Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man

Division of Medicine & Therapeutics, Ninewells Hospital & Medical School

Colin Farquharson

Division of Medicine & Therapeutics, Ninewells Hospital & Medical School

Allan D Struthers

Division of Medicine & Therapeutics, Ninewells Hospital & Medical School, a.d.struthers{at}dundee.ac.uk

Introduction

Losartan improves stimulated endothelial function in patients with cardiovascular disease, but there are no data to establish whether losartan has this effect in normal man. Furthermore, whether losartan improves basal nitric oxide (NO) activity is controversial. We therefore examined whether treatment with losartan improved basal NO activity in normal, salt-replete man. If so, this would imply that tonic levels of angiotensin II (Ang II) reduce tonic basal levels of NO, even in salt-replete normal man.

Methods

We performed a randomised, placebo-controlled, double-blind crossover study in 24 healthy volunteers, comparing losartan 50 mg daily for one month versus placebo. Brachial artery endothelial function was assessed by bilateral venous occlusion plethysmography, measuring the response to intra-arterial infusions of the endothelial-dependent and endothelial-independent vasodilators, acetylcholine and sodium nitroprusside respectively and the endothelial-dependent vasoconstrictor N^G-monomethyl-L-arginine. Results were analysed by multiple analysis of variance and statistical significance was taken as a p value of 0.05.

Results

Losartan significantly increased the vasoconstriction in response to N ^G-monomethyl-L-arginine (-37 2% vs. -32+2%, losartan vs. placebo; p=0.05). Losartan improved the vasodilatation response to acetylcholine; however, this result did not reach significance (214+2 0% vs. 174+20%, losartan vs. placebo; p=0.15). Losartan did not affect the response to nitroprusside (172+15% vs. 176+16%, losartan vs. placebo; p=0.84). There was no significant difference in blood pressure between the two study days.

Conclusions

Losartan improves basal NO bioactivity in healthy salt-replete volunteers. Even in salt-replete man, basal Ang II levels exert a tonic effect, which reduces basal NO.

Key Words: losartan • endothelium • nitric oxide • renin angiotensin system • angiotensin II

Journal of Renin-Angiotensin-Aldosterone System, Vol. 5, No. 2, 84-88 (2004)
DOI: 10.3317/jraas.2004.015


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF]